T1	CHEM 33 43	vitamina D
#1	AnnotatorNotes T1	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T2	DISO 70 88	parálisis cerebral
#2	AnnotatorNotes T2	C0007789; Cerebral Palsy; Disease or Syndrome
T3	PROC 90 134	Estudio preliminar controlado y aleatorizado
T4	PROC 324 345	suplementación con VD
#3	AnnotatorNotes T4	C4524013; Vitamin D supplementation; Therapeutic or Preventive Procedure
T5	DISO 164 182	parálisis cerebral
#4	AnnotatorNotes T5	C0007789; Cerebral Palsy; Disease or Syndrome
T6	DISO 184 186	PC
#5	AnnotatorNotes T6	C0007789; Cerebral Palsy; Disease or Syndrome
T7	DISO 211 236	deficiencia de vitamina D
#6	AnnotatorNotes T7	C0042870; Vitamin D Deficiency; Disease or Syndrome
T8	CHEM 1082 1084	VD
#7	AnnotatorNotes T8	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T9	DISO 289 291	PC
#8	AnnotatorNotes T9	C0007789; Cerebral Palsy; Disease or Syndrome
T10	PROC 443 495	concentraciones plasmáticas de 25-hidroxi-vitamina-D
#9	AnnotatorNotes T10	C2984945; 25-Hydroxyvitamin D Measurement; Laboratory Procedure
T11	ANAT 459 470	plasmáticas
#10	AnnotatorNotes T11	C0032105; Plasma; Body Substance
T12	CHEM 474 495	25-hidroxi-vitamina-D
#11	AnnotatorNotes T12	C0535968; 25-hydroxyvitamin D; Organic Chemical · Vitamin
T13	DISO 517 519	PC
#12	AnnotatorNotes T13	C0007789; Cerebral Palsy; Disease or Syndrome
T14	PROC 542 588	Estudio controlado, prospectivo y aleatorizado
#13	AnnotatorNotes T14	C0033522; Prospective Studies; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity
T15	DISO 639 641	PC
#14	AnnotatorNotes T15	C0007789; Cerebral Palsy; Disease or Syndrome
T16	PROC 934 950	gastrostomizados
#15	AnnotatorNotes T16	C0017196; Gastrostomy; Therapeutic or Preventive Procedure
T17	PROC 746 751	25OHD
#16	AnnotatorNotes T17	C2984945; 25-Hydroxyvitamin D Measurement; Laboratory Procedure
T18	PROC 1162 1167	25OHD
#17	AnnotatorNotes T18	C2984945; 25-Hydroxyvitamin D Measurement; Laboratory Procedure
T19	CHEM 821 823	D3
#18	AnnotatorNotes T19	C0008318; cholecalciferol; Organic Chemical · Pharmacologic Substance · Vitamin | C3265062; vitamin D3; Organic Chemical · Pharmacologic Substance · Vitamin
T20	PROC 1441 1449	calcemia
#19	AnnotatorNotes T20	C0729820; Blood calcium measurement; Laboratory Procedure
T21	PROC 864 871	placebo
#20	AnnotatorNotes T21	C0032042; Placebos; Therapeutic or Preventive Procedure
T22	DISO 958 970	desnutrición
#21	AnnotatorNotes T22	C0162429; Malnutrition; Disease or Syndrome
T23	DISO 978 988	postración
#22	AnnotatorNotes T23	C0277794; Extreme exhaustion; Sign or Symptom
T24	CHEM 1005 1020	antiepilépticos
#23	AnnotatorNotes T24	C0003299; Antiepileptic Agents; Pharmacologic Substance
T25	CHEM 1036 1051	antiepilépticos
#24	AnnotatorNotes T25	C0003299; Antiepileptic Agents; Pharmacologic Substance
T26	PROC 785 797	suplementado
#25	AnnotatorNotes T26	C0242297; Dietary Supplementation; Therapeutic or Preventive Procedure
T27	PROC 1454 1462	fosfemia
#26	AnnotatorNotes T27	C0853172; Blood phosphorus; Laboratory Procedure
T28	PROC 1523 1528	25OHD
#27	AnnotatorNotes T28	C2984945; 25-Hydroxyvitamin D Measurement; Laboratory Procedure
T29	CHEM 1753 1758	25OHD
#28	AnnotatorNotes T29	C0535968; 25-hydroxyvitamin D; Organic Chemical · Vitamin
T30	DISO 1772 1774	PC
#29	AnnotatorNotes T30	C0007789; Cerebral Palsy; Disease or Syndrome
T31	PROC 14 43	suplementación con vitamina D
#30	AnnotatorNotes T31	C4524013; Vitamin D supplementation; Therapeutic or Preventive Procedure
T32	ANAT 80 88	cerebral
#31	AnnotatorNotes T32	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T33	ANAT 174 182	cerebral
#32	AnnotatorNotes T33	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T34	CHEM 226 236	vitamina D
#33	AnnotatorNotes T34	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T35	CHEM 238 240	VD
#34	AnnotatorNotes T35	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T36	CHEM 283 285	VD
#35	AnnotatorNotes T36	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T37	CHEM 343 345	VD
#36	AnnotatorNotes T37	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T38	CHEM 420 422	VD
#37	AnnotatorNotes T38	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T39	PROC 683 734	Se registraron las variables clínicas y bioquímicas
T40	PROC 1098 1141	mediciones basales de variables bioquímicas
T41	PROC 1237 1242	25OHD
#38	AnnotatorNotes T41	C2984945; 25-Hydroxyvitamin D Measurement; Laboratory Procedure
T42	PROC 1468 1486	fosfatasa alcalina
#39	AnnotatorNotes T42	C0201850; Alkaline phosphatase measurement; Laboratory Procedure
T43	CHEM 1709 1711	VD
#40	AnnotatorNotes T43	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T44	PROC 401 422	suplementación con VD
#41	AnnotatorNotes T44	C4524013; Vitamin D supplementation; Therapeutic or Preventive Procedure
T45	PROC 497 502	25OHD
#42	AnnotatorNotes T45	C2984945; 25-Hydroxyvitamin D Measurement; Laboratory Procedure
T46	LIVB 60 65	niños
#43	AnnotatorNotes T46	C0008059; Child; Age Group
T47	LIVB 154 159	niños
#44	AnnotatorNotes T47	C0008059; Child; Age Group
T48	Spec_cue 201 210	riesgo de
T49	LIVB 355 364	pacientes
#45	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	LIVB 507 512	niños
#46	AnnotatorNotes T50	C0008059; Child; Age Group
T51	LIVB 522 531	Pacientes
#47	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	LIVB 607 612	niños
#48	AnnotatorNotes T52	C0008059; Child; Age Group
T53	Age 662 670	9,9 años
T55	Duration 764 773	8 semanas
T56	Dose 810 820	100.000 UI
T57	Route 824 828	oral
#49	AnnotatorNotes T57	C1527415; Oral Route of Drug administration; Functional Concept
T58	PHYS 1067 1084	metabolismo de VD
#50	AnnotatorNotes T58	C1159433; vitamin D metabolic process; Molecular Function
T61	LIVB 1298 1307	pacientes
#51	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T64	Duration 1424 1437	las 8 semanas
T65	Dose 1682 1705	monodosis de 100.000 UI
T66	LIVB 1762 1767	niños
#52	AnnotatorNotes T66	C0008059; Child; Age Group
T67	Dose 47 56	monodosis
T68	Dose 426 435	monodosis
T69	LIVB 626 633	varones
#53	AnnotatorNotes T69	C0025266; Male population group; Population Group
T70	Age 672 680	6,2-13,5
A1	Population_data T46 Age
A2	Population_data T47 Age
A3	Assertion T7 Speculated
A4	Population_data T50 Age
A5	Population_data T52 Age
A6	Population_data T66 Age
T54	CONC 1369 1380	diferencias
A7	Assertion T54 Negated
#54	AnnotatorNotes T54	C1705241; Delta (difference); Quantitative Concept
T59	Neg_cue 1352 1354	no
R1	Negation Arg1:T59 Arg2:T54	
T60	Neg_cue 1215 1217	No
T62	CONC 1223 1233	asociación
A8	Assertion T62 Negated
R2	Negation Arg1:T60 Arg2:T62	
T63	Spec_cue 1712 1718	podría
T71	Result_or_Value 1719 1729	normalizar
A9	Assertion T71 Speculated
R3	Used_for Arg1:T1 Arg2:T31	
T72	Observation 1 7	Efecto
#55	AnnotatorNotes T72	C1518681; Outcome of Therapy; Finding (?)
R4	Causes Arg1:T31 Arg2:T72	
R5	Experiences Arg1:T46 Arg2:T72	
R6	Experiences Arg1:T46 Arg2:T31	
R7	Has_Dose_or_Strength Arg1:T1 Arg2:T67	
R8	Experiences Arg1:T46 Arg2:T2	
R9	Location_of Arg1:T32 Arg2:T2	
R11	Experiences Arg1:T47 Arg2:T5	
R12	Location_of Arg1:T33 Arg2:T5	
R13	Location_of Arg1:T33 Arg2:T6	
R14	Experiences Arg1:T47 Arg2:T6	
R15	Before Arg1:T5 Arg2:T7	
R16	Causes Arg1:T34 Arg2:T7	
R17	Causes Arg1:T35 Arg2:T7	
R18	Speculation Arg1:T48 Arg2:T7	
R19	Before Arg1:T6 Arg2:T7	
R20	Experiences Arg1:T47 Arg2:T7	
R22	Used_for Arg1:T37 Arg2:T4	
R23	Experiences Arg1:T49 Arg2:T4	
R24	Experiences Arg1:T49 Arg2:T36	
R25	Experiences Arg1:T49 Arg2:T9	
R27	Used_for Arg1:T36 Arg2:T4	
T73	Observation 388 394	efecto
#56	AnnotatorNotes T73	C1518681; Outcome of Therapy; Finding (?)
R28	Causes Arg1:T44 Arg2:T73	
R29	Used_for Arg1:T38 Arg2:T44	
R30	Has_Dose_or_Strength Arg1:T38 Arg2:T68	
R31	Location_of Arg1:T11 Arg2:T10	
R34	Experiences Arg1:T50 Arg2:T13	
R35	Experiences Arg1:T50 Arg2:T45	
R36	Experiences Arg1:T50 Arg2:T10	
R37	Experiences Arg1:T50 Arg2:T44	
R38	Experiences Arg1:T50 Arg2:T73	
R40	Location_of Arg1:T11 Arg2:T45	
R41	Experiences Arg1:T52 Arg2:T15	
R42	Experiences Arg1:T69 Arg2:T15	
R43	Has_Age Arg1:T52 Arg2:T53	
R44	Has_Age Arg1:T52 Arg2:T70	
R45	Overlap Arg1:T17 Arg2:T55	
R46	Used_for Arg1:T19 Arg2:T26	
R47	Has_Dose_or_Strength Arg1:T19 Arg2:T56	
R48	Has_Route_or_Mode Arg1:T19 Arg2:T57	
T74	CONC 830 838	tiempo 0
R49	Overlap Arg1:T19 Arg2:T74	
R50	Overlap Arg1:T21 Arg2:T74	
T75	CONC 753 761	tiempo 0
R51	Overlap Arg1:T17 Arg2:T75	
R52	Causes Arg1:T25 Arg2:T58	
T76	Result_or_Value 1149 1157	normales
#57	AnnotatorNotes T76	C0459422; Normal result; Finding | C0586624; Normal laboratory finding; Finding
R53	Has_Result_or_Value Arg1:T40 Arg2:T76	
T77	Observation 1273 1295	Completaron el estudio
#58	AnnotatorNotes T77	C2732579; Completion of clinical trial; Finding
T78	Quantifier_or_Qualifier 1403 1420	variables basales
#59	AnnotatorNotes T78	C1442488; Baseline; Quantitative Concept
T79	Quantifier_or_Qualifier 1381 1395	significativas
A10	Assertion T79 Negated
#60	AnnotatorNotes T79	C0237881; Statistical Significance; Quantitative Concept
R55	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T79	
R56	Negation Arg1:T59 Arg2:T79	
R57	Overlap Arg1:T20 Arg2:T64	
R58	Overlap Arg1:T27 Arg2:T64	
R59	Overlap Arg1:T42 Arg2:T64	
T80	Result_or_Value 1494 1502	normales
#61	AnnotatorNotes T80	C0459422; Normal result; Finding | C0586624; Normal laboratory finding; Finding
R60	Has_Result_or_Value Arg1:T42 Arg2:T80	
R61	Has_Result_or_Value Arg1:T27 Arg2:T80	
R62	Has_Result_or_Value Arg1:T20 Arg2:T80	
T81	Quantifier_or_Qualifier 1172 1184	insuficiente
R63	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T81	
T82	Quantifier_or_Qualifier 1195 1205	deficiente
#62	AnnotatorNotes T82	C0011155; Deficiency; Functional Concept
R64	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T82	
#63	AnnotatorNotes T81	C0231180; Insufficient (qualifier); Qualitative Concept
T83	Quantifier_or_Qualifier 1564 1589	insuficiente + deficiente
#64	AnnotatorNotes T83	C0231180; Insufficient (qualifier); Qualitative Concept + C0011155; Deficiency; Functional Concept
R65	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T83	
T84	Result_or_Value 1547 1553	normal
#65	AnnotatorNotes T84	C0459422; Normal result; Finding | C0586624; Normal laboratory finding; Finding
T85	PROC 1734 1758	concentraciones de 25OHD
#66	AnnotatorNotes T85	C2984945; 25-Hydroxyvitamin D Measurement; Laboratory Procedure
R66	Experiences Arg1:T66 Arg2:T85	
R67	Experiences Arg1:T66 Arg2:T30	
R69	Speculation Arg1:T63 Arg2:T71	
R70	Has_Dose_or_Strength Arg1:T43 Arg2:T65	
R72	Experiences Arg1:T66 Arg2:T43	
R74	Overlap Arg1:T28 Arg2:T64	
T86	Result_or_Value 1600 1606	normal
#67	AnnotatorNotes T86	C0205307; Normal; Qualitative Concept
R75	Has_Result_or_Value Arg1:T28 Arg2:T84	
R76	Has_Result_or_Value Arg1:T28 Arg2:T86	
T87	CONC 1629 1650	test exacto de Fisher
#68	AnnotatorNotes T87	C1708064; Fisher's Exact Test; Intellectual Product
R10	Has_Route_or_Mode Arg1:T21 Arg2:T57	
#69	AnnotatorNotes T62	C0332281; Associated with; Qualitative Concept
#70	AnnotatorNotes T71	C0205307; Normal; Qualitative Concept
A11	Experiencer T61 Patient
A12	Experiencer T66 Patient
A13	Experiencer T49 Patient
A14	Experiencer T50 Patient
A15	Experiencer T51 Patient
A16	Experiencer T52 Patient
A17	Experiencer T69 Patient
A18	Experiencer T46 Patient
A19	Experiencer T47 Patient
R21	Has_Result_or_Value Arg1:T85 Arg2:T71	
